USEFULNESS OF SERUM MICRORNAS AS BIOMARKERS FOR PEDIATRIC METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

被引：0
|
作者：
Blakley, Caroline [1 ]
Nelson, Benjamin [2 ]
Qarooni, Shatha [3 ]
Lee, Wai Han [3 ]
Tryggestad, Jeanie [3 ]
Short, Kevin [3 ]
Palle, Sirish Kumar [3 ]
机构：
[1] Univ Oklahoma, Hlth & Sci Ctr, Norman, OK USA
[2] Harold Hamm Diabet Ctr HHDC, Norman, OK USA
[3] Univ Oklahoma, Hlth Sci Ctr, OUHSC, Dept Pediat, Norman, OK USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
829
引用
收藏
页码：S626 / S626
页数：1
相关论文
共 50 条
  • [21] Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) terminology in different clinical settings
    Iruzubieta, Paula
    Santos-Laso, Alvaro
    Arias-Loste, Maria Teresa
    Calleja, Jose Luis
    Crespo, Javier
    JOURNAL OF HEPATOLOGY, 2024, 80 (03) : e121 - e123
  • [22] Genome-wide Association Study on Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
    Darlay, Rebecca
    Zatorska, Michalina
    Worthington, Sarah
    Anstee, Quentin M.
    Daly, Ann K.
    Cordell, Heather J.
    GENETIC EPIDEMIOLOGY, 2024, 48 (07) : 352 - 352
  • [23] Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD)
    Wong, Robert J.
    METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (04):
  • [24] Cutting edge: ferroptosis in metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis and therapy
    El-Sehrawy, Amr Ali Mohamed Abdelgawwad
    Rashid, Teeba Ammar
    Ullah, Muhammad Ikram
    Uthirapathy, Subasini
    Ganesan, Subbulakshmi
    Singh, Abhayveer
    Devi, Anita
    Joshi, Kamal Kant
    Jasim, Ahmed Salman
    Kadhim, Abed J.
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2025, 25 (01)
  • [25] METALD, THE NEW CATEGORY OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) - HOW COMMON IS IT?
    Scheetz, Kate
    Kalagara, Sanah
    Vilar-Gomez, Eduardo
    Chalasani, Naga P.
    Vuppalanchi, Raj
    GASTROENTEROLOGY, 2024, 166 (05) : S477 - S478
  • [26] Novel insights of phenylalanine in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) and cardiovascular complications
    Liu, J.
    Chen, Y.
    Qian, J.
    Cui, R.
    Demirkan, A.
    Zheng, Y.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [27] Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Shin, Soyeon
    Kim, Jaeyoung
    Lee, Ju Yeon
    Kim, Jun
    Oh, Chang-Myung
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2023, 32 (04) : 289 - 302
  • [28] Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance
    Hutchison, Alan L.
    Tavaglione, Federica
    Romeo, Stefano
    Charlton, Michael
    JOURNAL OF HEPATOLOGY, 2023, 79 (06) : 1524 - 1541
  • [29] HEALTHCARE PROVIDERS' PERSPECTIVES ON NEW METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) NOMENCLATURE
    Albhaisi, Somaya
    Albhaisi, Omar
    HEPATOLOGY, 2024, 80 : S890 - S891
  • [30] Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Hamamah, Sevag
    Iatcu, Oana C.
    Covasa, Mihai
    NUTRIENTS, 2025, 17 (01)
12345